Company profile
Medicure Inc.
OTC: MCUJF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Winnipeg, MBCIK 0001133519Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 55
v0.1 · 5/100 weight · pillars only
↑ return on assets, listing tenure · ↓ filing timeliness, Piotroski F
Methodology →Revenue TTM
$22.7M
Rev growth YoY (TTM)
+45.4%
Net income (FY)
-$758.5k
Employees
23
as of 2026-08-23
Market cap
$10.0M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$758.5k-1.0M CAD2024
Total assets$20.6M29.7M CAD2024
Liabilities$6.2M8.9M CAD2024
Revenue by segment
Filed disclosures · FY2022
By product
Aggrastat100%
By geography
Not disclosed.
The read
What is Medicure Inc.’s financial profile?
Medicure Inc. earned -$758.5k in FY2024 net income.
Peers · Healthcare
PDS Biotechnology Corporation——Conavi Medical Corp.——Advanced Biomed Inc. Common Stock——Skye Bioscience, Inc.——Quince Therapeutics, Inc.——CalciMedica, Inc.——Key facts
CEOAlbert David Friesen
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersWinnipeg, MB
ExchangeOTC: MCUJF
Employees23
IPO date2004-02-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.